H.R.3674

Authorizes U.S. participation in the Davos Alzheimer’s Collaborative to combat Alzheimer’s disease and dementia globally.

The Global Alzheimer’s Initiative Now Act authorizes U.S. participation in the Davos Alzheimer’s Collaborative (DAC), a public-private-patient venture aimed at accelerating innovation in drug development and transforming healthcare systems' approach to Alzheimer’s disease and dementia. The bill highlights the growing prevalence of Alzheimer’s and dementia, particularly in low- and middle-income countries, and emphasizes the need for international cooperation. It also underscores the disproportionate impact on women and minority populations. The U.S.